Johnson & Johnson
Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25
27 Mar 2025
Impella heart pump upgraded to Class 2a in ACC/AHA treatment guideline for cardiogenic shock secondary to STEMI
New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)
26 Mar 2025
Oral presentation features new data from the 24-week pivotal Vivacity-MG3 study which show sustained disease control through treatment with nipocalimab on the clinician-assessed QMGa score in antibody
Johnson & Johnson MedTech Launches the DUALTO™ Energy System
25 Mar 2025
The DUALTO™ electrosurgical generator is designed to offer a simplified user experience, access to Polyphonic™ Fleet digital device management, and flexible application of monopolar, bipolar, ultrason
Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
21 Mar 2025
Investment builds on almost 140-year legacy of improving and saving lives and supporting American jobs Includes four planned new manufacturing facilities, with ground-breaking today in North Carolina
Johnson & Johnson to break ground on new state-of-the-art biologics facility in North Carolina to deliver market-leading portfolio of transformational therapies
21 Mar 2025
•New facility will support plans to advance J&J's portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases •Delivering on Company's plans fo
U.S. FDA approves TREMFYA
21 Mar 2025
TREMFYA® is the only IL-23i to demonstrate clinical remission and endoscopic response, both at one year, with a fully subcutaneous induction regimen Supported by data from the GALAXI study, TREMFYA® i
Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren’s disease, has now received Fast Track designation
18 Mar 2025
Sjögren’s disease (SjD) is a prevalent, debilitating autoantibody disease with no FDA-approved advanced treatments The Company is actively enrolling patients in the Phase 3 DAFFODIL study This marks the fourth nipocalimab FDA Fast Track designation
Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025
10 Mar 2025
Building on last year’s momentum of 18 FDA 510(k) Clearances and 45 global product launches, the company accelerates innovation across joint reconstruction, trauma, spine, and more
Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients
10 Mar 2025
Topline results also show investigational targeted oral peptide icotrokinra achieved clinical remission rates up to 30.2% at Week 12 and a favorable safety profile in Phase 2b ANTHEM-UC study Clinical
Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD
10 Mar 2025
No cure for IBD exists yet, but the FDA's approval of a Johnson & Johnson drug that may reduce symptoms marks progress in treatments for inflammatory bowel disease.
Featured
The history of safety glass
By Kiron Kasbekar | 26 Mar 2025
You probably already knew that the world’s VIPs move around in cars with bullet-proof glass windscreen and windows. But did you know that ‘bulletproof glass’ is not really bulletproof?
German silver: used in cutlery, music, electricals - but it’s not silver
By Kiron Kasbekar | 20 Mar 2025
This material, which was first developed in China, not Germany, and is an alloy of copper, nickel and zinc, has lost its sheen in home uses, but finds favor in electrical engineering.
Pioneers – the Wrights and Glenn Curtiss launched the aircraft industry
By Kiron Kasbekar | 17 Mar 2025
First Orville and Wilbur Wright flew their plane, the ‘Wright Flyer’, from near a small town called Kitty Hawk. Then Glenn Curtiss built planes with a very different system of controls, which has lasted until now.
What do aircraft have in common with bicycles and motorcycles?
By Kiron Kasbekar | 17 Mar 2025
From chains and sprockets to direct drives—If someone asked you what aircraft have in common with bicycles and motorcycles, how would you respond?
Radar’s ancestors: From sound mirrors to modern detection technology
By Kiron Kasbekar | 11 Mar 2025
Radar has become a well-settled technology today, especially in the field of navigation.
Nokia Bell Labs: innovations in communication, computing, technology
By Omar Almeida | 08 Mar 2025
Bell Laboratories, or Bell labs, which has now become Nokia Bell Labs, is one of the most renowned research and development organizations in the history of science and technology.
Company story – Quaker Oats
By Kiron Kasbekar | 08 Mar 2024
Quaker Oats is a company whose products I remember from my childhood days. Years before a foreign exchange crisis caused the Indian government to impose curbs on consumer product imports, we used to see a host of foreign brands in the Indian market. Including Quaker Oats, which I remember eating when I was a child, and which has been available for the past two decades or more.
How Quaker Oats grabbed customers’ attention
By Kiron Kasbekar | 07 Mar 2024
Quaker Oats, the American food products giant that was created in 1901 through the merger of many older oat millers, and was acquired by a bigger foods giant, Pepsi, in 2001, has been an innovative company. One example of its innovativeness shows in its packaging – the cereal box it launched in 1915.
Company story – Cunard Line
By Kiron Kasbekar | 12 Jan 2024
The Cunard Line started its life in Glasgow in 1839 as the British and North American Royal Mail Steam-Packet Company when Samuel Cunard was awarded the first British transatlantic steamship mail contract.
